• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Theses
  • Research Data
  • Projects
  • Organizations
  • Researchers
  • More
  • Collections
  • Statistics
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Proof of concept of a multimodal intravital molecular imaging system for tumour transpathology investigation.

Proof of concept of a multimodal intravital molecular imaging system for tumour transpathology investigation.

Details
Files
DOI
10.48350/162494
Publisher DOI
10.1007/s00259-021-05574-y
PubMed ID
34651225
Abstract
BACKGROUND

Transpathology highlights the interpretation of the underlying physiology behind molecular imaging. However, it remains challenging due to the discrepancies between in vivo and in vitro measurements and difficulties of precise co-registration between trans-scaled images. This study aims to develop a multimodal intravital molecular imaging (MIMI) system as a tool for in vivo tumour transpathology investigation.

METHODS

The proposed MIMI system integrates high-resolution positron imaging, magnetic resonance imaging (MRI) and microscopic imaging on a dorsal skin window chamber on an athymic nude rat. The window chamber frame was designed to be compatible with multimodal imaging and its fiducial markers were customized for precise physical alignment among modalities. The co-registration accuracy was evaluated based on phantoms with thin catheters. For proof of concept, tumour models of the human colorectal adenocarcinoma cell line HT-29 were imaged. The tissue within the window chamber was sectioned, fixed and haematoxylin-eosin (HE) stained for comparison with multimodal in vivo imaging.

RESULTS

The final MIMI system had a maximum field of view (FOV) of 18 mm × 18 mm. Using the fiducial markers and the tubing phantom, the co-registration errors are 0.18 ± 0.27 mm between MRI and positron imaging, 0.19 ± 0.22 mm between positron imaging and microscopic imaging and 0.15 ± 0.27 mm between MRI and microscopic imaging. A pilot test demonstrated that the MIMI system provides an integrative visualization of the tumour anatomy, vasculatures and metabolism of the in vivo tumour microenvironment, which was consistent with ex vivo pathology.

CONCLUSIONS

The established multimodal intravital imaging system provided a co-registered in vivo platform for trans-scale and transparent investigation of the underlying pathology behind imaging, which has the potential to enhance the translation of molecular imaging.
Date Issued
2022-03
Publication Type
Article
Subject(s)
600 Technology > 610 Medicine & health
Subjects
Fiducial marker Glycolysis imaging Intravital imaging Multimodal imaging Positron imaging Transpathology Tumour microenvironment Window chamber
Language(s)
en
Author(s)
Liu, Zhen
Cheng, Tao
Düwel, Stephan
Jian, Ziying
Topping, Geoffrey J
Steiger, Katja
Wang, Qian
Braren, Rickmer
Reder, Sybille
Mittelhäuser, Markus
Hundshammer, Christian
Feuerecker, Benedikt
Huang, Sung-Cheng
Schwaiger, Markus
Schilling, Franz
Ziegler, Sibylle I
Shi, Kuangyu  orcid-logo
Universitätsklinik für Nuklearmedizin  
Additional Credits
Universitätsklinik für Nuklearmedizin  
Journal
European journal of nuclear medicine and molecular imaging
Publisher
Springer
ISSN
1619-7089
Access(Rights)
open.access
Show full item
BORIS Portal
Bern Open Repository and Information System
Build: da6d1d [14.09. 16:14]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
  • Audiovisual Material
  • Software & other digital items
  • Events
More
  • About BORIS Portal
  • BORIS Portal & Open Science
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo
Repository logo COAR Notify